Bibliografia

1. De Leyn P, Lardinois D, Van Schil PE, Rami-Porta R, Passlick B, Zielinski M, Waller DA, Lerut T, Weder W. ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. European Journal of Cardio-thoracic Surgery 2007;32:1-8

2. Lee PC, Port JL, Korst RJ, Liss Y, Meherally DN, Altorki NK. Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer. Ann Thorac Surg. 2007;84(1):177-181

3. Veeramachaneni NK, Battafarano RJ, Meyers BF, Zoole JB, Patterson GA. Risk factors for occult nodal metastasis in clinical T1N0 lung cancer: a negative impact on survival. European Journal of Cardio-thoracic Surgery 2008;33:466-469

4. Silvestri GA, Gonzalez AV, Jantz MA, Margolis ML, Gould MK, Tanoue LT, Harris LJ, Detterbeck FC. Methods for Staging Non-small Cell Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2013; 143(5)(Suppl):e211S–e250S

5. Malcolm G Coulthard. Quantifying how tests reduce diagnostic uncertainty. Arch Dis Child 2007;92:404–408

6. Martínez-Olondris PP, Molina-Molina M, Xaubet A, Marrades RM, Luburich P, Ramírez J, Torres A, Agustí C. Punción transbronquial aspirativa en el estudio de las adenopatías mediastínicas: rentabilidad y coste-beneficio. Arch Bronconeumol. 2008;44:290-294

7. Alsharif M, Andrade RS, Groth SS, Stelow EB, Pambuccian SE. Endobronchial Ultrasound–Guided Transbronchial Fine-Needle Aspiration. Am J Clin Pathol 2008;130:434-443

8. Ceron L, Michieletto L, Zamperlin A. Mediastinal staging in lung cancer: a rational approach. Monaldi Arch Chest Dis 2009;71(4):170-175

9. Ceron L, Michieletto L, Zamperlin A, Mancino L. The Challenge of Mediastinal Staging. European Oncology & Haematology 2011;7(1):31-35

10. Saettele TM, Ost DE. Multimodality systematic approach to mediastinal lymph node staging in non-small cell lung cancer. Respirology 2014;19: 800–808

11. Takizawa T, Terashima M, Koike T, Watanabe T, Kurita Y, Yokoyama A, et al. Lymph node metastasis in small peripheral adenocarcinoma of the lung. J Thorac Cardiovasc Surg 1998;116:276-280

12. Wang J, Ma Y, Zhu ZH, Situ DR, Hu Y, Rong TH. Expression and prognostic relevance of tumor carcinoembryonic antigen in stage IB non-small cell lung cancer. J Thorac Dis 2012;4(5):490-496

13. Chen F, Yan CE, Li J, Han XH, Wang H, Qi J. Diagnostic value of CYFRA 21-1 and CEA for predicting lymph node metastasis in operable lung cancer. Int J Clin Exp Med 2015;8(6):9820-9824

14. Gould MK, Donington J, Lynch WR, Mazzone PJ, Midthun DE, Naidich DP, Wiener RS. Evaluation of Individuals With Pulmonary Nodules: When Is It Lung Cancer? Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2013; 143(5)(Suppl):e93S–e120S

15. Ceron L, Mancino L, Michieletto L, Zamperlin A. Bayesian approach to mediastinal staging of lung cancer: economic analysis. Rassegna di Patologia dell’Apparato Respiratorio 2013; 28: 258-264

16. Detterbeck F, Puchalski J, Rubinowitz A, Cheng D. Classifi cation of the Thoroughness of Mediastinal Staging of Lung Cancer. Chest 2010; 137(2):436–442

17. Kinsey CM, Arenberg DA. Endobronchial Ultrasound–guided Transbronchial Needle Aspiration for Non–Small Cell Lung Cancer Staging. Am J Respir Crit Care Med 2014;189(6): 640–649

18. Zhou Q, Suzuki K, Anami Y, Oh S, Takamochi K. Clinicopathologic features in resected subcentimeter lung cancer – status of lymph node metastases. Interactive CardioVascular and Thoracic Surgery 2010;10: 53–57

19. Seok Y, Yang HC, Kim TJ, Lee KW, Kim K, Jheon S, Cho S. Frequency of Lymph Node Metastasis According to the Size of Tumors in Resected Pulmonary Adenocarcinoma with a Size of 30 mm or Smaller. J Thorac Oncol. 2014;9: 818–824

20. Ketchedjian A, Daly BD, Fernando HC, Florin L, Hunter CJ, Morelli DM, Shemin RJ. Location as an important predictor of lymph node involvement for pulmonary adenocarcinoma. J Thorac Cardiovasc Surg. 2006 Sep;132(3):544-548

21. Choi YS, Shim YM, Kim J, Kim K. Mediastinoscopy in Patients With Clinical Stage I Non–Small Cell Lung Cancer. Ann Thorac Surg 2003;75:364–366

22. De Leyn P, Vansteenkiste J, Cuypers P, Deneffe G, Van Raemdonck D, Coosemans W, Verschakelen J, Lerut T. Role of cervical mediastinoscopy in staging of non-small cell lung cancer without enlarged mediastinal lymph nodes on CT scan. Eur J Cardiothorac Surg 1997 Nov;12(5):706-712

23. Defranchi SA, Cassivi SD, Nichols FC, Allen MS, Shen KR, Deschamps C, Wigle DA. N2 Disease in T1 Non-Small Cell Lung Cancer. Ann Thorac Surg. 2009; 88(3): 924–928

24. Wang J, Welch K, Wang L, Kong FM. Negative Predictive Value of Positron Emission Tomography and Computed Tomography for Stage T1-2N0 Non–Small-Cell Lung Cancer: A Meta-Analysis. Clin Lung Cancer. 2012; 13(2): 81–89

25. Alastair N. J. Graham, FRCS(Ed) K. John M. Chan, MB Ugo Pastorino, MD Peter Goldstraw. Systematic nodal dissection in the intrathoracic staging of patients with non-small cell lung cancer. J Thorac Cardiovasc Surg 1999;117:246-251

26. Riqueta M, Manac’ha D, Le Pimpec Barthesa F, Dujonb A, Debrossea D, Debesse B. Prognostic value of T and N in non small cell lung cancer three centimeters or less in diameter. European Journal of Cardio-thoracic Surgery 11 (1997) 440–444

27. Takamochi K, Nagai K, Suzuki K, Yoshida J, Ohde Y, Nishiwaki Y. Clinical Predictors of N2 Disease in Non-small Cell Lung Cancer. Chest 2000; 117:1577–1582

28. Suzuki K, Nagai K, Yoshida J, Nishimura M, Takahashi K, Nishiwaki Y. Clinical predictors of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer. J Thorac Cardiovasc Surg 1999;117:593-598

29. Al-Sarraf N, Aziz R, Gately K, Lucey J, Wilson L, McGovern E, Young V. Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography. European Journal of Cardio-thoracic Surgery 2008;33:104—109

30. Fibla JJ, Molins L, Simon C, Perez J, Vidal G. The Yield of Mediastinoscopy with Respect to Lymph NodeSize, Cell Type, and the Location of the Primary Tumor. J Thorac Oncol. 2006;1: 430–433

31. Takizawa T, Terashima M, Koike T, Watanabe T, Kurita Y, Yokoyama A, et al. Lymph node metastasis in small peripheral adenocarcinoma of the lung. J Thorac Cardiovasc Surg 1998;116:276-280

32. Asamura H, Nakayama H, Kondo H, Tsuchiya R, Shimosato Y, Naruke T. Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: are these carcinomas candidates for video-assisted lobectomy? J Thorac Cardiovasc Surg 1996;111:1125-1134)

33. Miller DL, Rowland CM, Deschamps C, Allen MS, Trastek VF, Pairolero PC. Surgical treatment of non-small cell lung cancer 1 cm or less in diameter. Ann Thorac Surg 2002;73:1545-1551

34. Detterbeck FC, Zelman Lewis S, Diekemper R, Addrizzo-Harris DJ, Alberts WM. Executive Summary. Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2013; 143(5)(Suppl):7S–37S

35. Watanabe S, Asamura H, Suzuki K, Tsuchiya R. Problems in diagnosis and surgical management of clinical N1 non-small cell lung cancer. Ann Thorac Surg 2005;79:1682-1685

36. T Hishida, J Yoshida, M Nishimura, Y Nishiwaki, K Nagai. Problems in the current diagnostic standards of clinical N1 non-small cell lung cancer. Thorax 2008;63:526–531